Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world multicenter single-arm study of Anjianning (adalimumab) in adults with moderate to severe active Crohn's disease
CTR20253184Phase 4Active
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Start
- Aug 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, sponsored by BioRay Pharmaceutical Co., Ltd.. Started Aug 2025; status: active.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20253184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253184.